Relafen 750, or Relafen, or Naproxcinod, or the medication represents a specific approach to pain control, viewed through a biochemical pharmacy perspective. A formulation, comprising naproxcinod, is designed to impact cyclooxygenase (COX) activity, notably COX-2, although demonstrating limited inhi